How Does a Therapy Qualify for Breakthrough Status?
For a therapy to qualify, there must be evidence from early clinical trials suggesting that the drug offers a substantial benefit over existing treatments. This could be in terms of increased efficacy, improved safety profile, or the ability to treat a condition for which no adequate therapy exists. The application process for this designation involves detailed submissions to the FDA, including clinical trial data and proposed mechanisms of action.
